CXCL8 and chronic obstructive pulmonary disease: One short-term study (10-week treatment) found no anti-inflammatory effects of ICS treatment investigating inflammatory mediators like IL-8, IL-10, neutrophil elastase in sputum in smokers with COPD, whereas limited beneficial effects were present in ex-smokers [16].